Даваа–Баасан 08:30–20:00 · Бямба 09:00–16:00
Now showing 1 - 2 of 2
  • Some of the metrics are blocked by your 
    Item type:Publication,
    A Study of Head injury-related mortality in Ulaanbaatar of Mongolia, 2018-2020
    Background: This study aims to determine the causes and risk factors of head injury cases, and causes of head injury-related mortality. Methodology: All deaths registered in Department of Forensic Medicine, National Institute Forensic Science, National Trauma and Orthopedic Research Center from 2018 to 2020, total 5450 mortality cases were reviewed and 536 head injury-related cases were collected for this study. Results: We reviewed 536 head injury-related deaths, which represented 8% of all mortality cases during 2018-2020. 470 (87.7%) were male and 66 (12.3%) were female. Male to female ratio was 7:1 and mean age was 42±15. Among head injury-related deaths, 363(67.7%) cases were from direct by firm and dull stuffs, 130(24.3%) from road traffic accidents and 34 (6.3%) falls from height. One hundred eighty three cases (34.1%) showed alcoholic consumption at the injury time. By the characteristics of injury, 286 (53.3%) cases showed subdural, 129 (24%) epidural hematoma, 400(74.6%) subarachnoid hemorrhage, and 332 (64%) cases showed cerebral contusion. Conclusion: Male adults have more deaths due to direct head injury from assaults. Head injury progresses to death by its own pathogenesis.
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Evaluation of glypican‑3 in patients with hepatocellular carcinoma
    (2025-01) ;
    Gurbadam, Unenbat
    ;
    ;
    Narmandakh, Nyam-Erdene
    ;
    Khatanbaatar, Gerelee
    Hepatocellular carcinoma (HCC) is one of the most common cancers occurring worldwide, including Mongolia. Although alpha-fetoprotein (AFP) is a widely used marker for HCC, conflicting studies have been published regarding its specificity and sensitivity towards HCC. Glypican-3 (GPC3) is a different promising biomarker for HCC, and there is some evidence to suggest that this protein may be a more specific marker compared with AFP. GPC3 has been shown to fulfill important roles in cell proliferation and division during embryogenesis, and is rarely found in the tissues of healthy adults. The aim of the present study was to investigate the levels of serum GPC3 (sGPC3) and tissue GPC3 in Mongolian patients with HCC. Serum samples from a total of 270 individuals [HCC group, 90 patients; risk group (RG), 90 subjects; and control group, 90 subjects] were evaluated using enzyme-linked immunosorbent assay to identify the sGPC3 levels. In addition, immunohistochemical analysis of the GPC3 was performed on tissue samples from 50 patients with HCC to evaluate the expression of GPC3. sGPC3 level was found to be significantly increased in the HCC group compared with the RG and the control group, with the area under the curve=0.85 (P<0.001). sGPC3 was found to be significantly associated with hepatitis C virus status and cirrhosis (P<0.05). In addition, the tissue expression of GPC3 was associated with the serum AFP (sAFP) level. Finally, positive staining of GPC3 was observed when the sAFP level of the patient was >20 ng/ml. In conclusion, the results from the present study have supported that GPC3 may be a promising marker for HCC, and can be used as a diagnostic marker alongside AFP.
    Scopus© Citations 11